2 Canadian Value Stocks to Buy if You Think 2022 Will Be Turbulent

Alimentation Couche-Tard (TSX:ATD.B) and TD Bank (TSX:TD)(NYSE:TD) are great Canadian value stocks to prepare for further market volatility.

| More on:

Many pundits are already viewing 2022 as a sub-par year for stocks, at least compared to 2021 and even 2020. Undoubtedly, there will be much in the way of surprises in the new year, and the bar set in 2021 will be hard to pass. Still, that doesn’t mean investors should look to sell their stocks in anticipation of a market correction or crash. However, it is a good idea to have just enough dry powder on the sidelines, so you’re able to buy on dips while being able to meet your personal liquidity situation.

At this juncture, American-heavy firms like Alimentation Couche-Tard (TSX:ATD.B) and TD Bank (TSX:TD)(NYSE:TD) seem like great Canadian value stocks to buy for 2022, even if it is poised to fall well shy of 2021 on a returns front. Remember, stock pickers don’t need to settle for market returns. If they pick their spots carefully, they can do better than what markets have to offer. And the following two value plays, I believe, improve one’s odds of doing very well, even if next year ends up being a less remarkable year for markets on the front of returns.

Couche-Tard

Couche-Tard is a convenience store kingpin that’s really seen the pace of M&A slow in recent years. Undoubtedly, many failed pursuits of big-league firms, including French grocery giant Carrefour and convenience store behemoth Caltex Australia, were big news in the financial media. While Couche has gone on to make bite-sized deals since the two needle-moving pursuits, the company still has the means to make a significant splash on the acquisition front. Sure, valuations have been quite stretched amid the market’s latest march higher. And that may be why it’s so hard for management to pull the trigger. Couche-Tard isn’t one for making deals that won’t create value or at least a good chance of creating value over the long run.

Couche’s silence, I believe, is a good thing. Come the next big downturn, expect Couche to get active with its incredibly healthy balance sheet. The discipline of management and its ability to double net income over the next five years makes the name a great buy for the long run.

For now, the stock trades at 16.3 times trailing earnings. That’s not a growth multiple. In fact, the price-to-earnings multiple has compressed from below the 20 times range over the past few years, likely because investors are skeptical over the firm’s growth prospects, as more EVs replace gas-fueled vehicles. I think the discount is completely unwarranted. Just look to the firm’s performance in EV-heavy markets like Norway and the retail innovation lab at McGill University. There’s a lot to like, as the firm’s store concepts change for the better.

As a consumer staple, Couche is likely to be a foundation for your portfolio if 2022 proves choppy.

TD Bank

TD Bank is a top Canadian bank that’s also seen its price-to-earnings multiple compress, as investors favoured its peers in recent quarters. Undoubtedly, TD hasn’t knocked one out of the ballpark in a while. It’s faded versus its peer group. But don’t think that TD is about to take a backseat to its younger brothers in the Big Six. It’s likely to outpace its peers once higher rates kick in, given the bank has a lot to gain from net interest margin expansion.

For now, TD is likely to trade in line with its peers. If a big acquisition is announced, or if rate hikes start coming in, though, TD could be ready to rally in a big way.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette owns shares of ALIMENTATION COUCHE-TARD INC and TORONTO-DOMINION BANK. The Motley Fool owns shares of and recommends ALIMENTATION COUCHE-TARD INC.

More on Investing

Beware of bad investing advice.
Investing

2 No-Brainer Growth Stocks to Buy Right Now for Less Than $500

Both of these top Canadian stocks have impressive track records and years of growth potential, making them two of the…

Read more »

telehealth stocks
Investing

Got $100? 3 Small-Cap Stocks to Buy and Hold Forever

Given their solid underlying businesses and healthy growth prospects, these three small-cap stocks can deliver superior returns in the long…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Investing

CAE Stock: Buy, Sell, or Hold in 2025?

With a record $18B backlog but a retiring CEO and Boeing delays clouding the outlook, is CAE stock's 6% dip…

Read more »

clock time
Dividend Stocks

Time to Buy This Canadian Stock That Hasn’t Been This Cheap in Years

This dividend stock may be down, but certainly do not count it out, especially as it holds a place in…

Read more »

Paper Canadian currency of various denominations
Dividend Stocks

Is Brookfield Infrastructure Stock a Buy for its 5% Dividend Yield?

Brookfield Infrastructure's 5% yield is attractive, but it's just the tip of the iceberg for why it's one of the…

Read more »

senior man smiles next to a light-filled window
Dividend Stocks

Buy 4,167 Shares of 1 Dividend Stock, Create $325/Month in Passive Income

This dividend stock has one strong outlook. Right now could be the best time to grab it while it offers…

Read more »

Canadian Dollars bills
Stocks for Beginners

3 No-Brainer Stocks to Buy Under $50

A $50 investment every month or every week can buy you one share of these three stocks, and earn you…

Read more »

Rocket lift off through the clouds
Investing

Top Canadian Stocks to Buy Now for Long-Term Growth

These top Canadian stocks operate in high-growth sectors and are witnessing significant tailwinds, which will drive multi-year growth.

Read more »